| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/29/1999 | WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders |
| 04/29/1999 | WO1999002736A3 Sr-bi nucleic acids and uses therefor |
| 04/29/1999 | WO1999001473A3 Anti-bacterial methods and materials |
| 04/29/1999 | WO1998059069A3 Method for identifying cancerigenic agents using a mammal with inhibition of the poly(adp-ribose)-polymerase |
| 04/29/1999 | WO1998044134A3 Bacterial plasmids |
| 04/29/1999 | WO1998030717A3 Vegetal sequences including a polymorphic site and their uses |
| 04/29/1999 | DE19746874A1 Isolation of nucleic acids |
| 04/29/1999 | CA2719432A1 Analyte assay using particulate labels |
| 04/29/1999 | CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods |
| 04/29/1999 | CA2307342A1 Method for suppressing multiple drug resistance in cancer cells |
| 04/29/1999 | CA2307330A1 Jmy, a co-activator for p300/cbp, nucleic acid encoding jmy and uses thereof |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306693A1 Cell lines useful for in vitro assay for identification of carcinogens |
| 04/29/1999 | CA2306629A1 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 04/29/1999 | CA2306445A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immunoreceptors |
| 04/29/1999 | CA2306251A1 Alpha-7 nicotinic receptor |
| 04/29/1999 | CA2305888A1 Zoogloeal and hyphomicrobium spp. nucleic acids |
| 04/29/1999 | CA2305613A1 Methods and apparatus for determining analytes in various matrices |
| 04/29/1999 | CA2273193A1 Novel human .beta.2 integrin alpha subunit |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911417A2 Enzyme-based assay for determining effects of exogenous and endogenous factors on cellular energy production |
| 04/28/1999 | EP0911411A1 Novel amino-terminal deblocking enzyme |
| 04/28/1999 | EP0911409A2 Deformylase |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911405A2 Gapdh |
| 04/28/1999 | EP0911403A2 MurB gene from Streptococcus pneumoniae |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911398A2 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911396A2 Methods for generating polynucleotides having desired characteristics by iterative selective and recombination |
| 04/28/1999 | EP0911390A2 Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0910794A1 Multilayer enzyme electrode membranes and methods of making same |
| 04/28/1999 | EP0910670A1 Covalent attachment of nucleic acid molecules onto solid-phases via disulfide bonds |
| 04/28/1999 | EP0910669A1 Isolated nucleic acid molecules which are members of the mage-b family and uses thereof |
| 04/28/1999 | EP0910668A1 Methods for detection of rearranged dna |
| 04/28/1999 | EP0910667A1 Nucleotide probes and method for determining hla dqb1 typing |
| 04/28/1999 | EP0910666A1 Quantitation of rna transcripts using genomic dna as the internal amplification competitor |
| 04/28/1999 | EP0910665A1 Identification of numerical changes in cell dna |
| 04/28/1999 | EP0910664A1 Synthesis of fluorophore-labeled dna |
| 04/28/1999 | EP0910663A1 Methods and compositions for determining the tumor suppressor status of cells |
| 04/28/1999 | EP0910662A1 Methods and reagents for typing hla class i genes |
| 04/28/1999 | EP0910651A1 Ozone-induced gene expression in plants |
| 04/28/1999 | EP0910646A1 Brain glycogen phosphorylase cancer antigen |
| 04/28/1999 | EP0910645A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/1999 | EP0910644A1 Retinoid metabolizing protein |
| 04/28/1999 | EP0910643A1 Ribonuclease resistant rna preparation and utilization |
| 04/28/1999 | EP0910641A1 Neural cell adhesion molecule splicing variants |
| 04/28/1999 | EP0910639A1 HUMAN cAMP-DEPENDENT PROTEIN KINASE INHIBITOR HOMOLOG |
| 04/28/1999 | EP0910636A1 Human b-cell antigens, related reagents |
| 04/28/1999 | EP0910577A2 Hypertonia gene |
| 04/28/1999 | EP0910570A1 Integrated nucleic acid hybridization devices based upon active surface chemistry |
| 04/28/1999 | EP0910409A1 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| 04/28/1999 | EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 04/28/1999 | EP0910403A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
| 04/28/1999 | EP0910401A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 04/28/1999 | EP0910340A1 Functionalized nanotubes |
| 04/28/1999 | EP0876509A4 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 04/28/1999 | EP0866854A4 Reducing tyramine interference in (met)amphetamine immunoassays |
| 04/28/1999 | EP0789705A4 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
| 04/28/1999 | EP0760003A4 Simultaneous enumeration of e. coli and total coliforms |
| 04/28/1999 | EP0728301B1 Cytological screening method |
| 04/28/1999 | EP0693048A4 Reduced temperature dna denaturation using glycerol |
| 04/28/1999 | EP0675967A4 Functional assay for tumor suppressor genes. |
| 04/28/1999 | EP0672191A4 Quantitative detection of macromolecules with fluorescent oligonucleotides. |
| 04/28/1999 | EP0647232B1 Deproteinization with azlactone-functional supports |
| 04/28/1999 | EP0637342B1 Process for typing of hcv isolates |
| 04/28/1999 | EP0456766B1 TYPE oc PLATELET-DERIVED GROWTH FACTOR RECEPTOR GENE |
| 04/28/1999 | CN1215336A Stable biocatalysts for ester hydrolysis |
| 04/28/1999 | CN1215165A Down's syndrome antenatal diagnosis method and reagent box |
| 04/28/1999 | CA2248274A1 Novel dbpa |
| 04/28/1999 | CA2248270A1 Novel dbpb |
| 04/27/1999 | US5898094 Rodent models displaying enhanced alzheimer's disease phenotypic and physiological characteristics; produced by breeding modified rodents and comparing mutant offspring to nonmutant rodents |
| 04/27/1999 | US5898066 Trophic factors for central nervous system regeneration |
| 04/27/1999 | US5898031 Oligoribonucleotides for cleaving RNA |
| 04/27/1999 | US5897999 Human cell line homozygous for defective p21 checkpoint gene ; treatment with gamma irradiation arrests cell in g2 phase with additional s phases |
| 04/27/1999 | US5897993 Simple and efficient analysis in vessel by dyeing bacteria, one step filtration by suction, collecting bacteria on hydrophobic membrane and removing excess coloring material; color intensity indicates quantity |
| 04/27/1999 | US5897990 Assays for measuring immunosuppressants by reporter gene expression |
| 04/27/1999 | US5897842 Exposing a mixture to different temperatures for pcr amplification, such as during genetic seqencing; flow-through reaction vessels, such as capillary tubes with sealing at proximal and distal end to prevent evaporation |
| 04/27/1999 | US5897782 Using active carbon fibers |
| 04/27/1999 | US5897475 Vaccines comprising enhanced antigenic helicobacter spp. |
| 04/27/1999 | CA2248119A1 Novel apt |
| 04/27/1999 | CA2248116A1 Novel muty |
| 04/27/1999 | CA1340516C Method and apparatus for amperometric diagnostic analysis |
| 04/27/1999 | CA1340511C Method of catalyzing chemical reactions using monoclonal antibodies |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/23/1999 | CA2245997A1 Novel compounds |
| 04/23/1999 | CA2239255A1 Cdna clone hneaa81 that encodes a human 7-transmembrane receptor |
| 04/23/1999 | CA2219049A1 Regulation-based strategies in the treatment of cancer |
| 04/22/1999 | WO1999019732A1 Methods and compositions for detecting hepatitis e virus |
| 04/22/1999 | WO1999019709A1 Sample collecting member and wiping inspection instrument |
| 04/22/1999 | WO1999019518A1 Screening for novel compounds which regulate biological interactions |
| 04/22/1999 | WO1999019517A1 Analysis of nicked dna by matched ion polynucleotide chromatography |
| 04/22/1999 | WO1999019515A1 Precision fluorescently dyed particles and methods of making and using same |
| 04/22/1999 | WO1999019514A1 Modifying double stranded dna to enhance separations by matched ion polynucleotide chromatography |
| 04/22/1999 | WO1999019513A2 Methods for detecting compounds which modulate the activity of an lpa receptor |
| 04/22/1999 | WO1999019512A1 β-ADRENERGIC RECEPTOR POLYMORPHISMS |
| 04/22/1999 | WO1999019511A1 In situ and in vitro hybridization method and buffer |
| 04/22/1999 | WO1999019510A1 Surface-bound, double-stranded dna protein arrays |
| 04/22/1999 | WO1999019509A2 Method and kit for amplification, sequencing and typing of classical hla class i genes |
| 04/22/1999 | WO1999019508A1 Susceptibility test for mycolic acid containing microorganisms |
| 04/22/1999 | WO1999019507A1 Biosensor electrode mediators for regeneration of cofactors |